Last synced on 6 December 2024 at 11:05 pm

LIAISON® XL Murex Anti-HBc and LIAISON® XL Murex Control Anti-HBc

Page Type
PMA Approval
PDF
FDA Hosted PDF
* The FDA doesn't provide PDFs for all submissions.
Applicant
DiaSorin Inc.
Trade Name
LIAISON XL MUREX Anti-HBc, LIAISON MUREX Control Anti-HBc
Generic Name
Test, hepatitis b (b core, be antigen, be antibody, b core igm)
Decision Date
1/2/2020
Days to Decision
463 days
Decision Code
APPR
FDA Decision
Approval